BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29631612)

  • 1. Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment.
    Fitzgerald S; Espina V; Liotta L; Sheehan KM; O'Grady A; Cummins R; O'Kennedy R; Kay EW; Kijanka GS
    J Transl Med; 2018 Apr; 16(1):89. PubMed ID: 29631612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients.
    Fitzgerald S; Sheehan KM; O'Grady A; Kenny D; O'Kennedy R; Kay EW; Kijanka GS
    J Gastroenterol Hepatol; 2013 Jun; 28(6):967-74. PubMed ID: 23425061
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Liu J; Han X; Chen L; Han D; Mu X; Hu X; Wu H; Wu H; Liu W; Zhao Y
    Aging (Albany NY); 2020 Oct; 12(20):20308-20331. PubMed ID: 33091876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
    Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
    Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal COX-2 signaling are correlated with colorectal cancer: A review.
    Su CW; Zhang Y; Zhu YT
    Crit Rev Oncol Hematol; 2016 Nov; 107():33-38. PubMed ID: 27823649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment.
    Park HH; Kim HR; Park SY; Hwang SM; Hong SM; Park S; Kang HC; Morgan MJ; Cha JH; Lee D; Roe JS; Kim YS
    Mol Cancer; 2021 Aug; 20(1):107. PubMed ID: 34419074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
    Ma J; Chang W; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells.
    Song X; Guo C; Zheng Y; Wang Y; Jin Z; Yin Y
    BMC Cancer; 2018 Oct; 18(1):971. PubMed ID: 30309319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
    Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
    Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
    Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
    Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer mouse models: integrating inflammation and the stroma.
    Ernst M; Ramsay RG
    J Gastroenterol Hepatol; 2012 Jan; 27(1):39-50. PubMed ID: 22188027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition.
    Sheehan KM; Gulmann C; Eichler GS; Weinstein JN; Barrett HL; Kay EW; Conroy RM; Liotta LA; Petricoin EF
    Oncogene; 2008 Jan; 27(3):323-31. PubMed ID: 17621268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance.
    Lamberti MJ; Rettel M; Krijgsveld J; Rivarola VA; Rumie Vittar NB
    Cell Oncol (Dordr); 2019 Apr; 42(2):173-196. PubMed ID: 30756254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
    Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H
    Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
    Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
    Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterising the prognostic potential of HLA-DR during colorectal cancer development.
    Dunne MR; Phelan JJ; Michielsen AJ; Maguire AA; Dunne C; Martin P; Noonan S; Tosetto M; Geraghty R; Fennelly D; Sheahan K; Ryan EJ; O'Sullivan J
    Cancer Immunol Immunother; 2020 Aug; 69(8):1577-1588. PubMed ID: 32306077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.